Events & Promotions
|
|
GMAT Club Daily Prep
Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.
Customized
for You
Track
Your Progress
Practice
Pays
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
May 2301:00 AM EDT
-02:00 AM EDT
At one point, she believed GMAT wasn’t for her. After scoring 595, self-doubt crept in and she questioned her potential. But instead of quitting, she made the right strategic changes. The result? A remarkable comeback to 695. Check out how Saakshi did it.
May 2310:00 AM PDT
-11:00 AM PDT
Video explanations + diagnosis of 10 weakest areas + 150+ short videos + study plan!
Jun 1006:00 AM PDT
-06:15 PM PDT
Register for the GMAT Club Virtual MBA Spotlight Fair – the world’s premier event for serious MBA candidates. This is your chance to hear directly from Admissions Directors at nearly every Top 30 MBA program..
28 Nov 2025, 22:37
Kudos
Bookmarks
Dropdown 1: fifth
Dropdown 2: $12
Be sure to select an answer first to save it in the Error Log before revealing the correct answer (OA)!
Difficulty:
85%
(hard)
Question Stats:
48% (02:26) correct
52%
(02:37)
wrong
based on 555
sessions
History
Date
Time
Result
Not Attempted Yet
Jivas Labs researches and commercially produces two types of drugs, analgesics and opioids. For the first few years after a drug’s commercial production begins, huge investments are made to set up the production and distribution chain for the new drug. As a result, the net profitability, which is calculated by subtracting investment expenses from the revenue from the drug, is negative. The graph represents the projected net profitability for the first 15 years of a newly-introduced analgesic and a newly-introduced opioid.
From each drop-down menu, select the option that creates the most accurate statement about these projections based on the given information.
The projected net profitability of the newly-introduced opioid is least at the end of the year since commercial production.
If net profitability is projected to grow, over the years 16 through 20, at the same rate as in years 10 through 15, the projected net profitability of the newly-introduced analgesic for the seventeenth year is approximately million.
Attachment:
GMAT-Club-Forum-6fc238s0.png [ 55.98 KiB | Viewed 2044 times ]
ShowHide Answer
Official Answer
Dropdown 1: fifth
Dropdown 2: $12
arushi118
Joined: 21 Jul 2024
Last visit: 19 May 2026
Posts: 266
Given Kudos: 894
Location: India
Concentration: Leadership, General Management
Schools: INSEAD Aug '26 LBS '26 Kellogg '26
GPA: 8.2/10
Products:
29 Nov 2025, 04:17
Kudos
Bookmarks
1st blank: The opioid is at its lowest at the end of the 5th year - the x-axis represents the number of years since production - so as the lowest point is at x=5 it means that it has been 5 years since they were produced - hence end of 5 years.
Hence, answer is "fifth"
2nd blank: slope of the line for analgesic: (10-5)/(15-10) = 1
So for 17th year: y - 10 = 1*(17-15) -> y=12
So, net projected profitability for 17th year will be $12 million.
Hence, answer is "fifth"
2nd blank: slope of the line for analgesic: (10-5)/(15-10) = 1
So for 17th year: y - 10 = 1*(17-15) -> y=12
So, net projected profitability for 17th year will be $12 million.
sunshineeee
09 Dec 2025, 07:02
Kudos
Bookmarks
ExpertsGlobal5
I was incorrect in Q2 and use the wrong method for translating 100% growth for the next 5 years, meaning 20% per year then at 17th year, got 2(20%) growth.
Please kindly explain the right way.
thanksss
I was incorrect in Q2 and use the wrong method for translating 100% growth for the next 5 years, meaning 20% per year then at 17th year, got 2(20%) growth.
Please kindly explain the right way.
thanksss
ExpertsGlobal5
